Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2020

01-05-2020 | Ultrasound | Original Article

What happens to muscles in fibromyalgia syndrome

Authors: Ebru Umay, Ibrahim Gundogdu, Erhan Arif Ozturk

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2020

Login to get access

Abstract

Background

The main somatic symptoms of fibromyalgia syndrome (FMS) are chronic musculoskeletal pain, stiffness, and fatigue, all of which are related to the muscle system and its functioning.

Aims

The aim of this study was to evaluate whether the asymptomatic upper and lower extremity muscles evaluated using ultrasonography (US) were different from healthy controls in both newly diagnosed and established FMS and to assess whether muscle measurements were related to fatigue and disease severity, as well as quality of life.

Methods

This study was conducted on 152 subjects (102 patients and 50 healthy controls) as a cross-sectional controlled trial. Real-time imaging of cross-sectional thickness (CST) (for deltoid, biceps brachii, triceps brachii, forearm flexor, tibialis anterior, and gastrocnemius medialis), and cross-sectional areas (CSAs) (quadriceps femoris (QF)) measurements were performed using US. Fatigue and disease severity as well as quality of life scales were given to all participants.

Results

In both patient groups, decreased QF muscle CSA was significantly correlated with increased fatigue severity and decreased overall quality of life and energy levels. Moreover, in patients with established disease, there was a significant correlation between the decrease in QF muscle CSA and increased social isolation and between the decrease in biceps brachii muscle CST and increased fatigue severity.

Conclusions

Whether in newly diagnosed or established disease, muscle measurement values and quality of life parameters were significantly decreased in patients with FMS compared with healthy controls.
Literature
1.
go back to reference Morin AK (2009) Fibromyalgia: a review of management options. Formulary 44:362–373 Morin AK (2009) Fibromyalgia: a review of management options. Formulary 44:362–373
2.
go back to reference Cohen H (2017) Controversies and challenges in fibromyalgia: a review and a proposal. Ther Adv Musculoskel Dis 9:115–127CrossRef Cohen H (2017) Controversies and challenges in fibromyalgia: a review and a proposal. Ther Adv Musculoskel Dis 9:115–127CrossRef
3.
go back to reference Ruiz-Montero PJ, Van Wilgen CP, Segura-Jiménez V et al (2015) Illness perception and fibromyalgia impact on female patients from Spain and the Netherlands: do cultural differences exist? Rheumatol Int 35:1985–1993CrossRef Ruiz-Montero PJ, Van Wilgen CP, Segura-Jiménez V et al (2015) Illness perception and fibromyalgia impact on female patients from Spain and the Netherlands: do cultural differences exist? Rheumatol Int 35:1985–1993CrossRef
4.
go back to reference Briones-Vozmediano E, Ronda-Pérez E, Vives-Cases C (2015) Fibromyalgia patients’ perceptions of the impact of the disease in the workplace. Aten Primaria 47:205–212CrossRef Briones-Vozmediano E, Ronda-Pérez E, Vives-Cases C (2015) Fibromyalgia patients’ perceptions of the impact of the disease in the workplace. Aten Primaria 47:205–212CrossRef
5.
go back to reference Góes SM, Leite N, Shay BL, Homann D, Stefanello JM, Rodacki AL (2012) Functional capacity, muscle strength and falls in women with fibromyalgia. Clin Biomech (Bristol, Avon) 27:578–583CrossRef Góes SM, Leite N, Shay BL, Homann D, Stefanello JM, Rodacki AL (2012) Functional capacity, muscle strength and falls in women with fibromyalgia. Clin Biomech (Bristol, Avon) 27:578–583CrossRef
6.
go back to reference Larsson A (2018) Controlled, cross-sectional, multi-center study of physical capacity and associated factors in women with fibromyalgia. BMC Musculoskelet Disord 19:121CrossRef Larsson A (2018) Controlled, cross-sectional, multi-center study of physical capacity and associated factors in women with fibromyalgia. BMC Musculoskelet Disord 19:121CrossRef
7.
go back to reference Pernambuco AP, Schetino LP, Viana RS, Carvalho LS, d’Avila Reis D (2015) The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 33:14–19 Pernambuco AP, Schetino LP, Viana RS, Carvalho LS, d’Avila Reis D (2015) The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 33:14–19
8.
go back to reference Srikuea R, Symons TB, Long DE, Lee JD, Shang Y, Chomentowski PJ, Yu G, Crofford LJ, Peterson CA (2013) Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum 65:519–528CrossRef Srikuea R, Symons TB, Long DE, Lee JD, Shang Y, Chomentowski PJ, Yu G, Crofford LJ, Peterson CA (2013) Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum 65:519–528CrossRef
9.
go back to reference Klaver-Król EG, Zwarts MJ, ten Klooster PM, Rasker JJ (2012) Abnormal muscle membrane function in fibromyalgia patients and its relationship to the number of tender points. Clin Exp Rheumatol 30:44–50PubMed Klaver-Król EG, Zwarts MJ, ten Klooster PM, Rasker JJ (2012) Abnormal muscle membrane function in fibromyalgia patients and its relationship to the number of tender points. Clin Exp Rheumatol 30:44–50PubMed
10.
go back to reference Sprott H, Salemi S, Gay RE, Bradley LA, Alarcón GS, Oh SJ, Michel BA, Gay S (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63:245–251CrossRef Sprott H, Salemi S, Gay RE, Bradley LA, Alarcón GS, Oh SJ, Michel BA, Gay S (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63:245–251CrossRef
11.
go back to reference Yunus MB, Kalyan-Raman UP, Kalyan-Raman K, Masi AT (1986) Pathologic changes in muscle in primary fibromyalgia syndrome. Am J Med 81:38–42CrossRef Yunus MB, Kalyan-Raman UP, Kalyan-Raman K, Masi AT (1986) Pathologic changes in muscle in primary fibromyalgia syndrome. Am J Med 81:38–42CrossRef
12.
go back to reference Bengtsson A, Henriksson KG, Larsson J (1986) Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 29:817–821CrossRef Bengtsson A, Henriksson KG, Larsson J (1986) Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 29:817–821CrossRef
13.
go back to reference Lund N, Bengtsson A, Thorborg P (1986) Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15:165–173CrossRef Lund N, Bengtsson A, Thorborg P (1986) Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15:165–173CrossRef
14.
go back to reference Grassi W, Core P, Carlino G, Salaffi F, Cervini C (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed Grassi W, Core P, Carlino G, Salaffi F, Cervini C (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed
15.
go back to reference Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G (1995) Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 24:34–37CrossRef Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G (1995) Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 24:34–37CrossRef
16.
go back to reference Schrøder HD, Drewes AM, Andreasen A (1993) Muscle biopsy in fibromyalgia. J Musculoskelet Pain 1:165–169CrossRef Schrøder HD, Drewes AM, Andreasen A (1993) Muscle biopsy in fibromyalgia. J Musculoskelet Pain 1:165–169CrossRef
17.
go back to reference Klaver-Król EG, Rasker JJ, Henriquez NR, Verheijen WG, Zwarts MJ (2012) Muscle fiber velocity and electromyographic signs of fatigue in fibromyalgia. Muscle Nerve 46:738–745CrossRef Klaver-Król EG, Rasker JJ, Henriquez NR, Verheijen WG, Zwarts MJ (2012) Muscle fiber velocity and electromyographic signs of fatigue in fibromyalgia. Muscle Nerve 46:738–745CrossRef
18.
go back to reference Akyol Y, Ulus Y, Tander B, Bilgici A, Kuru O (2013) Muscle strength, fatigue, functional capacity, and proprioceptive acuity in patients with fibromyalgia. Turk J Phys Med Rehab 59:292–298 Akyol Y, Ulus Y, Tander B, Bilgici A, Kuru O (2013) Muscle strength, fatigue, functional capacity, and proprioceptive acuity in patients with fibromyalgia. Turk J Phys Med Rehab 59:292–298
19.
go back to reference Koca I, Savas E, Ozturk ZA et al (2016) The evaluation in terms of sarcopenia of patients with fibromyalgia syndrome. Wien Klin Wochenschr 128:816–821CrossRef Koca I, Savas E, Ozturk ZA et al (2016) The evaluation in terms of sarcopenia of patients with fibromyalgia syndrome. Wien Klin Wochenschr 128:816–821CrossRef
20.
go back to reference Wolfe F, Hauser W (2011) Fibromyalgia diagnosis and diagnostic criteria. Ann Med 43:495–502CrossRef Wolfe F, Hauser W (2011) Fibromyalgia diagnosis and diagnostic criteria. Ann Med 43:495–502CrossRef
21.
go back to reference Nelson NL (2015) Muscle strengthening activities and fibromyalgia: a review of pain and strength outcomes. J Bodyw Mov Ther 19(2):370–376CrossRef Nelson NL (2015) Muscle strengthening activities and fibromyalgia: a review of pain and strength outcomes. J Bodyw Mov Ther 19(2):370–376CrossRef
22.
go back to reference Sprott H, Salemi S, Gay RE et al (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rhem Dis 63:245–251CrossRef Sprott H, Salemi S, Gay RE et al (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rhem Dis 63:245–251CrossRef
23.
go back to reference Morf S, Amann-Vesti B, Forster A et al (2005) Microcirculation abnormalities in patients with fibromyalgia-measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther 7:209–216CrossRef Morf S, Amann-Vesti B, Forster A et al (2005) Microcirculation abnormalities in patients with fibromyalgia-measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther 7:209–216CrossRef
24.
go back to reference McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC (2006) NO-mediated alteration in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120:161–169CrossRef McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC (2006) NO-mediated alteration in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120:161–169CrossRef
25.
go back to reference Gronemann ST, Ribel-Madsen S, Bartels EM, Danneskiold-Samsøe B, Bliddal H (2004) Collagen and muscle pathology in fibromyalgia patients. Rheumatology 43:27–31CrossRef Gronemann ST, Ribel-Madsen S, Bartels EM, Danneskiold-Samsøe B, Bliddal H (2004) Collagen and muscle pathology in fibromyalgia patients. Rheumatology 43:27–31CrossRef
26.
go back to reference Gerdle B, Ernberg M, Mannerkorpi K et al (2016) Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention: a case-control study. PLoS One 11:e0162010CrossRef Gerdle B, Ernberg M, Mannerkorpi K et al (2016) Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention: a case-control study. PLoS One 11:e0162010CrossRef
27.
go back to reference Hauser W, Klose P, Langhorst J et al (2010) Efficacy of different types of aerobic exercise in fibromyalgia: a systematic review and metaanalysis of randomized controlled trials. Arthritis Res Ther 12:R79CrossRef Hauser W, Klose P, Langhorst J et al (2010) Efficacy of different types of aerobic exercise in fibromyalgia: a systematic review and metaanalysis of randomized controlled trials. Arthritis Res Ther 12:R79CrossRef
28.
go back to reference Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ, Casimiro L, Robinson VA, McGowan J, Busch A, Poitras S, Moldofsky H, Harth M, Finestone HM, Nielson W, Haines-Wangda A, Russell-Doreleyers M, Lambert K, Marshall AD, Veilleux L, Ottawa Panel Members (2008) Ottowa panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther 88:857–871CrossRef Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ, Casimiro L, Robinson VA, McGowan J, Busch A, Poitras S, Moldofsky H, Harth M, Finestone HM, Nielson W, Haines-Wangda A, Russell-Doreleyers M, Lambert K, Marshall AD, Veilleux L, Ottawa Panel Members (2008) Ottowa panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther 88:857–871CrossRef
29.
go back to reference Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA (2008) Exercise for fibromyalgia: a systematic review. J Rheumatol 35:1130–1144 Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA (2008) Exercise for fibromyalgia: a systematic review. J Rheumatol 35:1130–1144
30.
go back to reference Maquet D, Croisier JL, Renard C, Crielaard JM (2002) Muscle performance in patients with fibromyalgia. Joint Bone Spine 69:293–299CrossRef Maquet D, Croisier JL, Renard C, Crielaard JM (2002) Muscle performance in patients with fibromyalgia. Joint Bone Spine 69:293–299CrossRef
31.
go back to reference Cardoso FS, Curtolo M, Natour J, Lombardi Júnior I (2011) Assessment of quality of life, muscle strength and functional capacity in women with fibromyalgia. Rev Bras Reumatol 51:344–350CrossRef Cardoso FS, Curtolo M, Natour J, Lombardi Júnior I (2011) Assessment of quality of life, muscle strength and functional capacity in women with fibromyalgia. Rev Bras Reumatol 51:344–350CrossRef
32.
go back to reference Hakkinen A, Hakkinen K, Hannonen P, Alen M (2000) Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women. J Rheumatol 27:1277–1282PubMed Hakkinen A, Hakkinen K, Hannonen P, Alen M (2000) Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women. J Rheumatol 27:1277–1282PubMed
33.
go back to reference Miller TA, Allen GM, Gandevia SC (1996) Muscle force, perceived effort, and voluntary activation of the elbow flexors assessed with sensitive twitch interpolation in fibromyalgia. J Rheumatol 23:1621–1627PubMed Miller TA, Allen GM, Gandevia SC (1996) Muscle force, perceived effort, and voluntary activation of the elbow flexors assessed with sensitive twitch interpolation in fibromyalgia. J Rheumatol 23:1621–1627PubMed
34.
go back to reference McLoughlin MJ, Colbert LH, Stegner AJ, Cook DB (2011) Are women with fibromyalgia less physically active than healthy women? Med Sci Sports Exerc 43:905–912CrossRef McLoughlin MJ, Colbert LH, Stegner AJ, Cook DB (2011) Are women with fibromyalgia less physically active than healthy women? Med Sci Sports Exerc 43:905–912CrossRef
35.
go back to reference Santos R, Armada-da-Silva PAS (2017) Reproducibility of ultrasound-derived muscle thickness and echo-intensity for the entire quadriceps femoris muscle. Radiography (Lond) 23:51–61CrossRef Santos R, Armada-da-Silva PAS (2017) Reproducibility of ultrasound-derived muscle thickness and echo-intensity for the entire quadriceps femoris muscle. Radiography (Lond) 23:51–61CrossRef
36.
go back to reference Rudrappa SS, Wilkinson DJ, Greenhaff PL, Smith K, Idris I, Atherton PJ (2016) Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance—a qualitative review. Front Physiol 7:361CrossRef Rudrappa SS, Wilkinson DJ, Greenhaff PL, Smith K, Idris I, Atherton PJ (2016) Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance—a qualitative review. Front Physiol 7:361CrossRef
37.
go back to reference Zhang SF, Zhang Y, Li B, Chen N (2018) Physical inactivity induces the atrophy of skeletal muscle of rats through activating AMPK/FoxO3 signal pathway. Eur Rev Med Pharmacol Sci 22(1):199–209PubMed Zhang SF, Zhang Y, Li B, Chen N (2018) Physical inactivity induces the atrophy of skeletal muscle of rats through activating AMPK/FoxO3 signal pathway. Eur Rev Med Pharmacol Sci 22(1):199–209PubMed
38.
go back to reference Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, le Couteur DG, Creasey H, Waite LM, Seibel MJ, Sambrook PN (2010) Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the concord health and ageing in men project. J Am Geriatr Soc 58:2055–2062CrossRef Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, le Couteur DG, Creasey H, Waite LM, Seibel MJ, Sambrook PN (2010) Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the concord health and ageing in men project. J Am Geriatr Soc 58:2055–2062CrossRef
40.
go back to reference Ruggiero L, Manganelli F, Santoro L (2018) Muscle pain syndromes and fibromyalgia: the role of muscle biopsy. Curr Opin Support Palliat Care 12(3):382–387CrossRef Ruggiero L, Manganelli F, Santoro L (2018) Muscle pain syndromes and fibromyalgia: the role of muscle biopsy. Curr Opin Support Palliat Care 12(3):382–387CrossRef
Metadata
Title
What happens to muscles in fibromyalgia syndrome
Authors
Ebru Umay
Ibrahim Gundogdu
Erhan Arif Ozturk
Publication date
01-05-2020
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2020
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-019-02138-w

Other articles of this Issue 2/2020

Irish Journal of Medical Science (1971 -) 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.